Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1Phase 1 1

Status

Completed 4Recruiting 2Active not recruiting 2Terminated 1

Sponsor Class

OTHER 50NETWORK 22NIH 6INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 3Genitourinary 1

Conditions

Hodgkin Disease 3Lymphoma 2Hematologic Diseases 1Carcinoma, Renal Cell 1

Interventions

Paclitaxel 490Carboplatin 436Gemcitabine 394Docetaxel 385Cisplatin 360pembrolizumab 344Bevacizumab 335Nivolumab 261Pemetrexed 243Capecitabine 221Dexamethasone 213Fluorouracil 211Rituximab 203Trastuzumab 193Cyclophosphamide 190Oxaliplatin 160Erlotinib Hydrochloride 147Ipilimumab 145atezolizumab 144Prednisone 144Cetuximab 142Irinotecan 139Leucovorin 130Doxorubicin 130Sorafenib 120Lenalidomide 119Bortezomib 118Sunitinib 107Everolimus 93130-nm albumin-bound paclitaxel 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × INDUSTRY × Vinblastine × Clear all
NCT01712490 2026-02-27

A Frontline Therapy Trial in Participants With Advanced Classical Hodgkin Lymphoma

Takeda

Phase 3 Completed
1,334 enrolled 23 charts
Lymphoid

Hodgkin Disease, Lymphoma

NCT02181738 2023-11-28

CheckMate 205

Bristol-Myers Squibb

Phase 2 Completed
294 enrolled 32 charts
Lymphoid

Hodgkin Disease

NCT01060904 2014-12-18

A Phase 1 Study of Brentuximab Vedotin Combined With Multi-Agent Chemotherapy for Hodgkin Lymphoma

Seagen Inc.

Phase 1 Completed
51 enrolled
Lymphoid

Hematologic Diseases, Hodgkin Disease, Lymphoma

NCT00520403 2014-10-13

A Study of Avastin (Bevacizumab) in Combination With Standard Therapy in Patients With Metastatic Renal Cell Cancer.

Hoffmann-La Roche

Phase 2 Completed
25 enrolled 8 charts
Genitourinary

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡